E-LIB Suche - Ergebnisse für: Sarsour, Khaled

1

Assessing ascertainment bias in atrial fibrillation across ..:

Hulstaert, Lars ; Boehme, Amelia ; Hood, Kaitlin...
PLOS ONE. 19 (2024) 4 - p. e0301991 , 2024

Link: https://doi.org/10.1371/..

2

Enhancing site selection strategies in clinical trial recru..:

Hulstaert, Lars ; Twick, Isabell ; Sarsour, Khaled..
PLOS ONE. 19 (2024) 3 - p. e0300109 , 2024

Link: https://doi.org/10.1371/..

3

2659. Substantially Elevated Influenza Risk in Vaccinated I..:

Zemlianskaia, Natalia ; Zheutlin, Amanda ; Murata, Yoshihiko...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

Durability of Protection Post–Primary COVID-19 Vaccination ..:

Zheutlin, Amanda ; Ott, Miles ; Sun, Ran...
Vaccines. 10 (2022) 9 - p. 1458 , 2022

Link: https://doi.org/10.3390/..

5

Impact of Immune Checkpoint Inhibitors on COVID-19 Severity..:

Tan, Ruoding ; Yun, Cindy ; Seetasith, Arpamas...
The Oncologist. 27 (2022) 3 - p. 236-243 , 2022

Link: https://doi.org/10.1093/..

6

External Comparator Groups Derived from Real-world Data Use..:

Carrigan, Gillis ; Bradbury, Brian D. ; Brookhart, M. Alan...
Current Epidemiology Reports. 9 (2022) 4 - p. 326-337 , 2022

Link: https://doi.org/10.1007/..

7

Association of biological antirheumatic therapy with risk f..:

Paul, Sanjoy K ; Montvida, Olga ; Best, Jennie H...
BMJ Open. 11 (2021) 6 - p. e042246 , 2021

Link: https://doi.org/10.1136/..

8

Rituximab utilization for approved and off‐label nononcolog..:

Sarsour, Khaled ; Beckley‐Kartey, Senam ; Melega, Simone...
Pharmacology Research & Perspectives. 8 (2020) 1 - p. , 2020

Link: https://doi.org/10.1002/..

9

Risk of malignancy associated with use of tocilizumab versu..:

Kim, Seoyoung C. ; Pawar, Ajinkya ; Desai, Rishi J....
Seminars in Arthritis and Rheumatism. 49 (2019) 2 - p. 222-228 , 2019

Link: https://doi.org/10.1016/..

10

Characterizing Disease Manifestations and Treatment Pattern..:

Gale, Sara L. ; Trinh, Huong ; Mathew, Nitya...
Rheumatology and Therapy. 7 (2019) 1 - p. 89-99 , 2019

Link: https://doi.org/10.1007/..

11

Incidence and Risk of Glucocorticoid‐Associated Adverse Eff..:

Wilson, Jessica C. ; Sarsour, Khaled ; Gale, Sara...
Arthritis Care & Research. 71 (2019) 4 - p. 498-511 , 2019

Link: https://doi.org/10.1002/..

12

No difference in cardiovascular risk of tocilizumab versus ..:

Kim, Seoyoung C. ; Solomon, Daniel H. ; Rogers, James R....
Seminars in Arthritis and Rheumatism. 48 (2018) 3 - p. 399-405 , 2018

Link: https://doi.org/10.1016/..

13

Effectiveness of biologic and non-biologic antirheumatic dr..:

Paul, Sanjoy Ketan ; Montvida, Olga ; Best, Jennie H....
Seminars in Arthritis and Rheumatism. 47 (2018) 4 - p. 478-484 , 2018

Link: https://doi.org/10.1016/..

14

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis ..:

Kim, Seoyoung C. ; Solomon, Daniel H. ; Rogers, James R....
Arthritis & Rheumatology. 69 (2017) 6 - p. 1154-1164 , 2017

Link: https://doi.org/10.1002/..

15

Incidence of outcomes potentially associated with corticost..:

Wilson, Jessica C. ; Sarsour, Khaled ; Collinson, Neil...
Seminars in Arthritis and Rheumatism. 46 (2017) 5 - p. 650-656 , 2017

Link: https://doi.org/10.1016/..